Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India

Akash Khobragade, Suresh Bhate, Vijendra Ramaiah, Shrikant Deshpande, Krishna Giri, Himanshu Phophle, Pravin Dinkar Supe, Inderjeet Godara, Ramesh Revanna, Rajnish Nagarkar,

The Lancet · 2022 · 248 citations · 5 references

DOIFull text

Open access

Concepts

References

5